In India, the first outbreak of Xia was reported in Ahmedabad in January 2017.
The Indian Science Research (ICMR), which was reported in Madhya Pradesh, Rajasthan and Gujarat, will be tested soon after the vaccine developed soon.
The second phase of the ICMR vaccine will be taken to ensure vaccine effectiveness and safety. A senior official said.
The vaccine manufacturer, Hyderabad-based Bharat Biotech has developed a vaccine. The vaccine is administered by an infection that occurs as an infectious disease infected by the Asian Sikya virus and African viruses.
"We did not know about Sica in India as the company developed a vaccine two years ago and only limited to Latin America.
The regulatory approval process for the implementation of the trial will start shortly.
Two died in Bhopal. A total of 120 cases were reported in the state.
The Ministry of Health has also reviewed the situation and review the situation in Madhya Pradesh and resume a plan to be implemented in Jaipur and Ahmedabad. In Rajasthan, 159 cases were reported.
In India, Zia's first outbreak occurred in Ahmedabad in January 2017 and in July in Krishnagiri district of Tamil Nadu. The two successful outbreaks are successful and successfully successful through vector management.
A 85-year-old woman was tested in Jaipur on September 22 while she was infected with the virus. Since then, Sica cases have risen to 153.
The veterinary control of Madhya Pradesh has also intensified vector control. The municipalities have been advised to take steps to check mosquito breeding.
The state health department advises pregnant women not to visit the affected areas.